JDD Buzz | Impact of Weight Loss on Soft Tissue
From news articles to social media, “Ozempic face” is commonly used to describe facial changes that accompany rapid weight loss from GLP-1 receptor agonists. A gaunt, sunken, and aged appearance is commonly attributed to Ozempic and other GLP-1s. However, bariatric surgery and dietary changes can also lead to skin laxity and loss of facial volume. …
Continue reading “JDD Buzz | Impact of Weight Loss on Soft Tissue”
JDD Buzz Series | Patient Perspectives on Scalp Biopsies for CCCA
Scalp biopsies are an important tool in diagnosing central centrifugal cicatricial alopecia (CCCA), especially in atypical presentations where making an accurate diagnosis through other means is challenging. Even though a biopsy-confirmed diagnosis could lead to hair-saving treatment, hair loss patients sometimes balk at the recommendation to biopsy. The authors of a brief communication published in …
Continue reading “JDD Buzz Series | Patient Perspectives on Scalp Biopsies for CCCA”
JDD April 2026 Highlights
Welcome to the April edition the JDD Highlights! Each month, we dive into the Journal of Drugs in Dermatology to bring you the most impactful research and clinical updates selected by the editor. This month’s selection reflects the rapidly evolving landscape of modern dermatology. From the diagnostic precision of Artificial Intelligence in nail disorders to …
JDD Buzz Series | Topical Nonsteroidal Therapies for Atopic Dermatitis
Topical corticosteroids have been a mainstay of frontline therapy for atopic dermatitis (AD) for more than half a century. Now therapeutic advances are challenging that standard of care. Nonsteroidal topicals — topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE-4 inhibitors — are expanding pathways of addressing the signs and symptoms of AD. An article …
Continue reading “JDD Buzz Series | Topical Nonsteroidal Therapies for Atopic Dermatitis”
JDD March 2026 Issue Highlights
The March issue of the Journal of Drugs in Dermatology (JDD) gathers a timely, practice‑oriented collection of studies and reports selected as this month’s Editor’s Picks — spanning potential disease‑modifying implications of antiviral therapy, long‑term biologic data, evolving topical and systemic options for inflammatory skin disease, and a range of hair‑ and nail‑focused investigations that …
JDD Buzz Series | Reddit Eczema vs. AAD Guidelines
When a patient reveals they went online for health information, it’s tempting for a clinician to inwardly groan. Fears of self-diagnosis or misinformation about diagnosed conditions can make clinicians concerned when patients seek medical information through online forums and social media. Yet these virtual communities are incredibly popular, most notably Reddit and its discussion forums. …
Continue reading “JDD Buzz Series | Reddit Eczema vs. AAD Guidelines”
JDD February 2026 Issue Highlights
Welcome to “JDD February 2026 Issue Highlights,” your quick tour of this month’s Editor’s Picks from the Journal of Drugs in Dermatology, curated by the Next Steps in Derm Team. This issue pairs practical algorithms, novel therapeutics, real‑world effectiveness data, equity analyses, and procedural reports, all with immediate clinical relevance. Explore this month’s top picks …
JDD Buzz Series | Cutaneous Adverse Events of GLP-1 Agonists
GLP-1 receptor agonists are an increasingly popular treatment for type 2 diabetes and obesity. Additionally, some dermatologists are finding success with treating psoriasis and hidradenitis suppurativa with GLP-1s independent of an impact on weight loss. As GLP-1 use becomes even more common in medicine, it’s important to understand side effects, including skin effects that could …
Continue reading “JDD Buzz Series | Cutaneous Adverse Events of GLP-1 Agonists”
JDD January 2026 Issue Highlights
Welcome to “JDD January 2026 Issue Highlights,” your guided tour through this month’s must-read studies, curated by the Journal of Drugs in Dermatology Editorial Team. This issue carries a Special Focus on Aesthetic Treatments, bringing together practical safety analyses, regulatory perspectives on regenerative medicine, advances in pigmentary and procedural care, and health‑equity research that informs …
Pyoderma Gangrenosum Following Total Colectomy for Ulcerative Colitis
Introduction Pyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis characterized by rapidly enlarging, painful ulcers with violaceous and undermined borders. It is commonly associated with systemic disorders, including rheumatoid arthritis, hematologic malignancies, and inflammatory bowel disease (IBD).¹ While PG often correlates with IBD flares, its pathogenesis is not well understood. Colectomy has been used to …
Continue reading “Pyoderma Gangrenosum Following Total Colectomy for Ulcerative Colitis”